- Home
- MX vs ORMP Comparison
MX vs ORMP Comparison
Compare MX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MX | ORMP |
|---|---|---|
| Founded | 2003 | 2002 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.7M | 197.6M |
| IPO Year | 2007 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MX | ORMP |
|---|---|---|
| Price | $2.38 | $4.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 758.5K | 123.5K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 5.91% |
| EPS Growth | 43.06 | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | ★ $178,860,000.00 | $2,000,000.00 |
| Revenue This Year | $5.39 | N/A |
| Revenue Next Year | $6.37 | N/A |
| P/E Ratio | ★ N/A | $1.53 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $2.18 | $2.09 |
| 52 Week High | $9.86 | $5.47 |
Technical Indicators
Market Signals| Indicator | MX | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 34.33 | 38.77 |
| Support Level | N/A | $3.90 |
| Resistance Level | $3.06 | $4.22 |
| Average True Range (ATR) | 0.13 | 0.15 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 3.63 | 52.50 |
Price Performance
Historical ComparisonAbout MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The Company operates within a single operating segment, Power Solutions business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.